( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1201.45
1103.37
1346.02
859.67
Total Expenditure
1171.88
1088.56
1256.4
889.28
PBIDT (Excl OI)
29.56
14.80
89.61
-29.61
Other Income
170.71
14.1
11.49
40.43
Operating Profit
200.28
28.91
101.11
10.82
Interest
30.85
29.67
26.76
26.64
Exceptional Items
-2.41
NA
NA
NA
PBDT
167.02
-0.75
74.35
-15.82
Depreciation
79.16
81.03
79.87
62.46
Profit Before Tax
87.86
-81.78
-5.51
-78.27
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
69.13
-49.85
3.29
-76.14
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
69.13
-49.85
3.29
-76.14
Minority Interest
NA
NA
NA
NA
Shares of Associates
-0.16
0.04
0.03
0.03
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
68.95
-49.81
3.32
-76.12
Equity Capital
174.86
174.86
174.86
174.86
Calculated EPS
1.97
-1.42
0.09
-2.17
Calculated EPS (Annualised)
7.88
-5.69
0.37
-8.70
No of Public Share Holdings
13818317
13815992
13815992
13915992
% of Public Share Holdings
39.51
39.5
39.5
39.79
PBIDTM% (Excl OI)
2.46
1.34
6.65
-3.44
PBDTM%
13.90
-0.06
5.52
-1.84